The basic physiology and pathophysiology of melatonin

被引:645
作者
Claustrat, B
Brun, J
Chazot, G
机构
[1] Hop NeuroCardiol, Ctr Med Nucl, Serv Radiol, Serv Radioanalyse, F-69394 Lyon 03, France
[2] Hop NeuroCardiol, Serv Neurol, F-69394 Lyon 03, France
关键词
melatonin; human; circadian rhythms; physiology; pathophysiology;
D O I
10.1016/j.smrv.2004.08.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Metatonin is a methoxyindole synthesized and secreted principally by the pineal gland at night under normal environmental conditions. The endogenous rhythm of secretion is generated by the suprachiasmatic nuclei and entrained to the light/dark cycle. Light is able to either suppress or synchronize melatonin production according to the tight schedule. The nycthohmeral rhythm of this hormone can be determined by repeated measurement of plasma or saliva melatonin or urine sulfatoxymelatonin, the main hepatic metabolite. The primary physiological function of melatonin, whose secretion adjusts to night Length, is to convey information concerning the daily cycle of light and darkness to body physiology. This information is used for the organisation of functions, which respond to changes in the photoperiod such as the seasonal rhythms. Seasonal rhythmicity of physiological functions in humans related to possible alteration of the melatonin message remains, however, of limited evidence in temperate areas in field conditions. Also, the daily melatonin secretion, which is a very robust biochemical signal of night, can be used for the organisation of circadian rhythms. Although functions of this hormone in humans are mainly based on correlative observations, there is some evidence that melatonin stabilises and strengthens coupling of circadian rhythms, especially of core temperature and steep-wake rhythms. The circadian organisation of other physiological functions could depend on the melatonin signal, for instance immune, antioxidative defences, hemostasis and glucose regulation. Since the regulating system of melatonin secretion is complex, following central and autonomic pathways, there are many pathophysiological situations where the melatonin secretion can be disturbed. The resulting alteration could increase predisposition to disease, add to the severity of symptoms or modify the course and outcome of the disorder. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:11 / 24
页数:14
相关论文
共 123 条
[61]  
LEWY AJ, 1994, CHRONOBIOL INT, V60, P105
[62]  
LEWY AJ, 1978, CATECHOLAMINES BASIC, V2, P1173
[63]   Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial [J].
Lissoni, P ;
Chilelli, M ;
Villa, S ;
Cerizza, L ;
Tancini, G .
JOURNAL OF PINEAL RESEARCH, 2003, 35 (01) :12-15
[64]   Localization of Aa-nat mRNA in the rat retina by fluorescence in situ hybridization and laser capture microdissection [J].
Liu, CM ;
Fukuhara, C ;
Wessel, JH ;
Iuvone, PM ;
Tosini, G .
CELL AND TISSUE RESEARCH, 2004, 315 (02) :197-201
[65]   Extraocular light exposure does not suppress plasma melatonin in humans [J].
Lockley, SW ;
Skene, DJ ;
Thapan, K ;
English, J ;
Ribeiro, D ;
Haimov, I ;
Hampton, S ;
Middleton, B ;
von Schantz, M ;
Arendt, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (09) :3369-3372
[66]  
Luboshitzky R, 2002, NEUROENDOCRINOL LETT, V23, P213
[67]   Clearance of melatonin and 6-sulfatoxymelatonin by hemodialysis in patients with end-stage renal disease [J].
Lüdemann, P ;
Zwernemann, S ;
Lerchl, A .
JOURNAL OF PINEAL RESEARCH, 2001, 31 (03) :222-227
[68]   Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study [J].
Lusardi, P ;
Piazza, E ;
Fogari, R .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (05) :423-427
[69]   The relationship between 6-sulphatoxymelatonin rhythm phase and age in self-reported good sleeping controls and sleep maintenance insomniacs aged 55-80 years [J].
Lushington, K ;
Dawson, D ;
Kennaway, DJ ;
Lack, L .
PSYCHOPHARMACOLOGY, 1999, 147 (01) :111-112
[70]  
Manev H, 1996, RESTOR NEUROL NEUROS, V9, P251, DOI 10.3233/RNN-1996-9408